🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Empagliflozin & Metformin (Test)

Found 14 matching trials

The Efficacy and Safety of Empagliflozin - Linagliptin and Empagliflozin- Metformin Therapy in Reduction of Body Weight in Type 2 Diabetic Patients .

PHASE4

The goal of this clinical trial is - Comparison of Empagliflozin - Linaglip...

Status

Completed

Location

Bahria University

Start Date

2022-12-01

Trial ID

NCT07247656

Treatments Being Tested

(Empagliflozin 10 mg+ Tab Linagliptin 5mg)Tab Empagliflozin 10 mg + Tab Metformin 500 mg

Clinical Study to Determine Bioequivalence Between Two Oral Medications of Empagliflozin/Metformin in 5 mg / 850 mg Tablets Under Fed Conditions.

Prospective, longitudinal, single-dose, randomized, open-label, crossover 2...

Status

Completed

Location

Axis Clinicals Latina, S.A. de C.V.

Start Date

2025-02-17

Trial ID

NCT07633015

Treatments Being Tested

Test. Empagliflozin/metformin 5/850 mg Synjardy 5/850 mg tablet, Reference

Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic of CKD-501, D745, and D150 for Healthy Subjects in Fed State.

PHASE1

This is a Randomized, open-label, single oral dosing, two-sequence, and two...

Status

Completed

Location

Chung-Ang University Gwangmyeong Hospital

Start Date

2024-04-04

Trial ID

NCT06483243

Treatments Being Tested

Test: CKD-383, Reference1: Duvie Tab. 0.5mg, Reference2: Jardiance tablets 25 mg, Reference3: GLUCOPHAGE XR TAB. 1000MG

Clinical Study to Determine Bioequivalence Between Two Oral Medications of Empagliflozin/Metformin in 12.5 mg / 500 mg Tablets Under Fed Conditions.

Prospective, longitudinal, single-dose, randomized, open-label, crossover 2...

Status

Completed

Location

Axis Clinicals Latina, S.A. de C.V.

Start Date

2025-09-10

Trial ID

NCT07633054

Treatments Being Tested

Synjardy 5/850 mg tablet, Reference Empagliflozin/metformin 12.5/500 mg test

Bioequivalence Study of Empagliflozin & Metformin HCL From Empagliform 12.5/1000 mg F.C.T (Hikma Pharma, Egypt) and Synjardy 12.5/1000 mg F.C.T (Boehringer Ingelheim International GmbH, Germany)

PHASE1

Comparative randomized, single dose, two-way crossover open-label study to ...

Status

Completed

Location

Genuine Research Center GRC

Start Date

2019-03-26

Trial ID

NCT05132023

Treatments Being Tested

Empagliflozin & Metformin (Test)Empagliflozin & Metformin (Reference)

This Study in Healthy People Tests Whether Taking a Low Strength of Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills

PHASE1

The primary objective of this trial is to establish the bioequivalence of t...

Status

Completed

Location

Humanpharmakologisches Zentrum Biberach

Start Date

2018-08-27

Trial ID

NCT03629054

Treatments Being Tested

Empagliflozin, Metformin HCl, Linagliptin (fixed dose combination)Empagliflozin Linagliptin Metformin HCl

A Clinical Trial to Evaluate the Food Effect on Pharmacokinetic Profiles and Safety of CKD-379

PHASE1

This is a randomized, open-label, single dose, crossover, phase Ⅰ trial to ...

Status

Completed

Location

Seoul National University Bundang Hospital

Start Date

2023-11-21

Trial ID

NCT06204107

Treatments Being Tested

CKD-379(Empagliflozin+sitagliptin+metformin) Test drug CKD-379(Empagliflozin+sitagliptin+metformin) Reference drug

This Study Tests Whether Taking the Medicines Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills. The Study is Done in Healthy Men and Women and Measures the Amount of Each Medicine in the Blood

PHASE1

To establish the bioequivalence of one fixed dose combination (FDC) tablet ...

Status

Completed

Location

Humanpharmakologisches Zentrum Biberach

Start Date

2017-08-31

Trial ID

NCT03259490

Treatments Being Tested

Empagliflozin/linagliptin/metformin HCl Empagliflozin Linagliptin Metformin HCl

Clinical Study to Determine Bioequivalence Between Two Oral Medications of Empagliflozin/Metformin in 12.5 mg / 850 mg Tablets Under Fed Conditions.

Prospective, longitudinal, single-dose, randomized, open-label, crossover 2...

Status

Completed

Location

Axis Clinicals Latina, S.A. de C.V.

Start Date

2025-02-10

Trial ID

NCT07633028

Treatments Being Tested

Empagliflozin/metformin 12.5/850 mg tablet (test)Synjardy 12.5/850 mg tablet (Reference)

Demonstrate Bioequivalence of Two 12.5 mg Empagliflozin/500 mg Metformin Fixed Dose Combination Tablets With Free Combination of Empagliflozin 25 mg and Metformin 1000 mg in Healthy Male and Female Volunteers Under Fed Conditions

PHASE1

Bioequivalence of two 12.5 mg empagliflozin/500 mg metformin fixed dose com...

Status

Completed

Location

1276.27.001 Boehringer Ingelheim Investigational Site

Start Date

2015-09

Trial ID

NCT02577315

Treatments Being Tested

Empagliflozin Metformin Empagliflozin Metformin

Previous Next